کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4982883 1454251 2017 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Review ArticleCurrent trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes
ترجمه فارسی عنوان
بررسی روند ماده در جریان تحویل دارو برای انبار انسولین زیر جلدی برای درمان دیابت
موضوعات مرتبط
مهندسی و علوم پایه مهندسی شیمی شیمی کلوئیدی و سطحی
چکیده انگلیسی


- Diabetes treatment using repeated insulin injections cause patient non-compliance.
- One strategy is to reduce number of injections, and research in this direction is promising.
- This is achieved with sustained release insulin depots.
- The review critically analyses the basis for such sustained release technologies available in the market.
- It appears new nanosystems provide immense potential for reducing daily injections.

Diabetes mellitus (DM) is a metabolic disorder due to irregularities in glucose metabolism, as a result of insulin disregulation. Chronic DM (Type 1) is treated by daily insulin injections by subcutaneous route. Daily injections cause serious patient non-compliance and medication non-adherence. Insulin Depots (ID) are parenteral formulations designed to release the insulin over a specified period of time, to control the plasma blood glucose level for intended duration. Physiologically, pancreas produces and secretes insulin in basal and pulsatile mode into the blood. Delivery systems mimicking basal release profiles are known as open-loop systems and current marketed products are open-loop systems. Future trend in open-loop systems is to reduce the number of injections per week by enhancing duration of action, by modifying the depot properties. The next generation technologies are closed-loop systems that mimic the pulsatile mode of delivery by pancreas. In closed-loop systems insulin will be released in response to plasma glucose. This review focuses on future trend in open-loop systems; by understanding (a) the secretion of insulin from pancreas, (b) the insulin regulation normal and in DM, (c) insulin depots and (d) the recent progress in open-loop depot technology particularly with respect to nanosystems.

136Insulin injections; numerous opportunities for technological improvement.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Colloids and Surfaces B: Biointerfaces - Volume 153, 1 May 2017, Pages 123-131
نویسندگان
, , ,